|
|
|
|
Section Of Gastroenterology
Clinical Faculty
•
Charles M. Bliss, Jr., M.D.
•
Lizabeth Cline, M.S.R.N., C.S., A.N.P.
•
Francis Farraye, M.D., M.Sc.
•
Albena Halpert, MD
•
Christopher S. Huang, MD
•
Brian Jacobson, M.D., M.P.H.
•
David R. Lichtenstein, M.D.
•
Robert C. Lowe, M.D.
•
Daniel S. Mishkin, M.D.,C.M.
•
T. Carlton Moore, M.D.
•
David P. Nunes, M.D.
•
Jaime Oviedo, M.D.
•
Marcos C. Pedrosa, M.D., M.P.H.
•
Angela C. Reffel, PA-C
•
Lawrence J. Saubermann, M.D.
•
Elihu M. Schimmel, M.D.
•
Paul C. Schroy III, M.D., M.P.H.
•
Satish K. Singh, M.D.
•
Chi-Chuan Tseng, M.D., Ph.D., M.P.H.
•
H. Christian Weber, M.D.
•
M. Michael Wolfe, M.D.
|
|
|
|
M. Michael Wolfe, M.D.
M. Michael Wolfe, M.D. is Chief of the Section of Gastroenterology at
Boston Medical Center and Boston University School of Medicine, where he
is also Professor of Medicine and Research Professor of Physiology and
Biophysics. A native of Akron, Ohio (USA), Dr. Wolfe received his
undergraduate and medical training at Ohio State University. Following
his graduation from medical school, he completed a residency in internal
medicine at the Medical College of Pennsylvania, where he served as
Chief Medical Resident. In 1979, Dr. Wolfe began his research and
clinical fellowships in gastroenterology at the University of Florida,
where he gained considerable expertise in the regulation of gastric acid
secretion and peptic ulcer disease, as well as in the field of
gastrointestinal regulatory peptides. In 1985, Dr. Wolfe relocated to
Harvard Medical School, where he continued his investigative career and
became one of the pioneers in studies that examined the transcriptional
regulation of these peptides. His current research interests include
the transcriptional regulation and physiological and pathological
significance of glucose-dependent insulinotropic polypeptide. He is
also conducting investigation aimed at determining the molecular
mechanisms and intracellular pathways involved in mediating the trophic
effects of gastrin on colorectal cancer and other malignancies of the
gastrointestinal tract. His clinical investigation includes the
management of acid-related disorders and novel methods for the treatment
and prevention of obesity.
Dr. Wolfe has also achieved significant recognition for his continued
interest in acid-related disorders and specifically GERD and
NSAID-associated gastroduodenal ulcers and in the diagnosis and
management of gastrinoma and other neuroendocrine tumors. He is a
Fellow of the American College of Physicians and American College of
Gastroenterology and is presently a member of the Education Committee of
the American Gastroenterological Association (AGA). He was formerly
Chair of the Constitution and Bylaws Committee, a member of the Research
Committee, and Chair of the GERD Awareness Program (GAP) of the AGA. In
addition to his numerous and significant contributions to the
gastroenterological literature, he serves on the editorial boards of
Digestive Diseases and Sciences and Alimentary Pharmacology and
Therapeutics. Dr. Wolfe has served as editor of several clinical
medicine textbooks, including his role as Editor-in-Chief of Therapy of
Digestive Disorders and co-author of Heartburn: Extinguishing the Fire
Inside. In all, he has authored or co-authored approximately 200
original scientific manuscripts, chapters, reviews, and abstracts. He
is a member of the ZRG F10 Study Section of the National Institutes of
Health and is Chair of the Advisory Board for Gastrointestinal Drugs at
the U.S. Food and Drug Administration.
|
|
